• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Solara Active Pharma Sciences Limited — Board Meeting, 06-02-2026: Outcome of Board Meeting

    06-02-2026 | 01:47 pm

    Solara Active Pharma's Board approved Q3 FY26 consolidated results: Revenue ₹349 Cr, Net Loss ₹17.43 Cr (9M Loss ₹17.01 Cr). Company faces accumulated losses, plans to raise ₹134.99 Cr via pending rights issue call to ensure going concern.

    No comments yet. Be the first to comment!

    All announcements from Solara Active Pharma Sciences Limited